Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Glenn Insider Profile
4 Followers
John Glenn, Chief Financial Officer at Solta Medical Inc, holds 10.98K shares in EKSO BIONICS (Ticker: EKSO), holds 0.00 shares in Solta Medical Inc (Ticker: SLTM).
John Glenn Solta Medical Inc (SLTM)Chief Financial Officer
Solta Medical Inc (SLTM)
Chief Financial Officer
Not Ranked
John Glenn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO
Roles that John Glenn holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Glenn
John Glenn's Trading History
Solta Medical Inc
Jan 24, 2014
―
Uninformative Sell
986.85K
―
EKSO BIONICS
Apr 02, 2020
CFO
Uninformative Buy
―
$62.81K
List of latest transactions for each holding click on a transaction to see John Glenn's performance on stock
You May Also Like
John Glenn insider profile FAQ
What is the percentage of profitable transactions made by John Glenn?
The percentage of profitable transactions made by John Glenn is ―.
What is the average return per transaction made by John Glenn?
The average return per transaction made by John Glenn is ―.
What stocks does John Glenn hold?
John Glenn holds: SLTM, EKSO stocks.
What was John Glenn’s latest transaction?
John Glenn latest transaction was an Uninformative Buy of ―.
What was John Glenn's most profitable transaction?
John Glenn’s most profitable transaction was an Informative Sell of EKSO stock on June 19, 2019. The return on the trade was 82.40%.
What is John Glenn's role in Solta Medical Inc?
John Glenn's role in Solta Medical Inc is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.